Metagenomics Market Size, Share & Trends Analysis Report By Technology (Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing), By Product, By Workflow, By Application, By Region, And Segment Forecasts, 2023 - 2030

Research Methodology

A three-pronged approach was followed for deducing the metagenomics market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for metagenomics market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of metagenomics market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Metagenomics Market Categorization:

The metagenomics market was categorized into five segments, namely technology (Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing), product (Kits & Reagents, Sequencing & Data Analytics Services, Software), application (Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food & Nutrition), workflow (Pre-sequencing, Sequencing, Data Analysis), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

Segment Market Methodology:

The metagenomics market was segmented into technology, product, application, workflow, and region. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The metagenomics market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico, Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Metagenomics market companies & financials:

The metagenomics market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• Bio-Rad Laboratories, Inc. - Bio-Rad Laboratories, Inc. provides tools and services for life sciences research, food science, and clinical diagnostics markets. The company has a global network of operations. It offers solutions to advance scientific R&D and introduce new technology in proteomics, genomics, food safety, medical diagnostics, drug discovery, and more. Furthermore, Bio-Rad’s business is segmented into life sciences and clinical diagnostics. The life sciences segment is involved in developing, manufacturing, & marketing reagents, laboratory instruments, and apparatus used in clinical research & food testing regimes. Furthermore, the company’s clinical diagnostics segment sells, manufactures, & supports test kits, test systems, specialized quality controls, and informatics systems that serve clinical laboratories in the diagnostics market.

• Illumina, Inc. - Illumina Inc.’s primary business includes developing, manufacturing, & distributing integrated platforms and systems for sequencing. The company is involved in analyzing and investigating genomic & proteomic information, determining biological function, and expressing a gene sequence. The company provides Next-Generation Sequencing (NGS) platforms for genotyping, sequencing, and gene expression analysis. It has a major presence in the North America and Europe NGS markets. This company develops novel sequencing technologies to reduce the cost of sequencing whole genomes. It offers genomic and molecular diagnostic products & services to cater to oncology, microbial genomics, drug development, agrigenomics, forensic genomics, infectious diseases surveillance, molecular epidemiology, and translational research involving HLA sequencing and associated applications.

• PerkinElmer, Inc. - PerkinElmer, Inc. (formerly Perkin-Elmer) offers technologies and services that enable researchers, scientists, & professionals to conduct various scientific experiments and analyses. Its products & services cover analytical instruments, reagents, consumables, software, and services. The company’s solutions are applied in diverse fields, including genomics, proteomics, drug discovery, environmental monitoring, and diagnostics. It has a global presence with offices, manufacturing facilities, and distribution channels worldwide. Recently, the company was rebranded to Revvity.

• Thermo Fisher Scientific, Inc. - Thermo Fisher Scientific, Inc. manufactures & provides laboratory reagents, equipment, analytical instruments, consumables, and diagnostic products. The company operates through numerous brands, including Thermo Scientific, Applied Biosystems, Fisher Scientific, Invitrogen, and Unity Lab Services. It operates through four reportable segments: specialty diagnostics, life sciences solutions, analytical instruments, and laboratory products & services. The life sciences solutions segment includes clinical NGS, biosciences, bioproduction, and genetic sciences. The biosciences segment offers cell culture media, reagents, consumables, & instruments to help customers conduct medical & biological research and discover new vaccines & drugs. The company provides services to pharmaceutical & biotechnology companies, clinical diagnostics laboratories, hospitals, government agencies, and research institutes.

• Novogene Co., Ltd. - Novogene Co., Ltd. is a global genomics and bioinformatics company specializing in comprehensive genomic and metagenomic research solutions. The company offers cutting- edge sequencing services, bioinformatics analysis, and personalized genomics solutions. Novogene provides advanced genomics and metagenomics research product portfolio and applications in the rapidly evolving life sciences industry.

• Promega Corporation - Promega Corporation offers a diverse portfolio of products and services designed to support scientific research & discovery across various fields, including molecular and cell biology, genomics, drug discovery, and diagnostics. Promega's offerings include reagents, enzymes, assays, instruments, and systems that researchers in academic, pharmaceutical, & biotechnology laboratories worldwide use. The company strongly emphasizes developing technologies for advancements in DNA & RNA

• QIAGEN - QIAGEN is a biotechnology-based company operating globally in over 20 countries. Its key business areas include assay technologies for molecular diagnostics, pharmaceutical, academic, and applied testing. The company’s product portfolio comprises various molecular testing applications. It markets over 500 products, including consumable kits and automation systems. Furthermore, its molecular technologies are utilized by forensic technicians. The company is also involved in isolating genetic material from biological samples. Key customers include healthcare providers, pharmaceutical & biotechnology companies, government or industry customers, and researchers.

• Takara Bio, Inc. - Takara Bio, Inc. is a global biotechnology company renowned for its innovative solutions in life sciences. The company has an international presence and is a pivotal player in the biotechnology & genomics sectors. The company is widely recognized for its diverse product portfolio, encompassing reagents, instruments, and services that cater to various aspects of molecular biology, genomics, and metagenomics research.

• Oxford Nanopore Technologies plc. - Oxford Nanopore Technologies plc. specializes in developing nanopore-based electronic systems for sensing biological molecules. The company was established as Oxford NanoLabs Ltd. and renamed Oxford Nanopore Technologies plc. in 2008. Its product portfolio includes MinION, PromethION, and GridION, which can analyze proteins, small molecules, DNA, & RNA. The company operates across various verticals, such as personalized medicines, scientific research, crop science, environmental applications, security, and defense. It operates as a subsidiary of IP Group PLC.

• F. Hoffmann-La Roche Ltd. - F. Hoffmann-La Roche Ltd. is a healthcare company with business operations in pharmaceuticals and diagnostics. Roche Diagnostics comprises Roche Professional Diagnostics (RPD), Roche Molecular Diagnostics (RMD), Roche Tissue Diagnostics, and Roche Diabetes Care. RMD, a segment of Roche Diagnostics, develops, manufactures, and distributes tests based on Polymerase Chain Reaction (PCR) technology & medical diagnostic products, platforms, and services.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Metagenomics Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Metagenomics Market Report Assumptions:

• The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.